Skip to main content

ACR Convergence 2022 Main banner

Schedule at a Glance

Scientific Session

Rheumatoid arthritis (RA)

Session: ACR Guidelines for Vaccination in Patients with Rheumatic and Musculoskeletal Diseases

Panel Discussion/Q&A

Saturday, November 12, 2022

5:10 PM – 5:30 PM Eastern Time

Location: Exhibit Hall A

Panelist(s)

Anne Bass, MD

Hospital for Special Surgery, Weill Cornell Medicine
New York, NY, United States

Disclosure: Disclosure(s): No financial relationships with ineligible companies to disclose
CB

Clifton O. Bingham, III, MD

Johns Hopkins University
Baltimore, MD, United States

Disclosure: Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Consultant (Terminated); Gilead: Consultant (Terminated); Janssen: Consultant (Ongoing); Moderna: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Regeneron: Consultant (Terminated); Sanofi: Consultant (Ongoing)
Kevin Winthrop

Oregon Health & Science University
portland, OR, United States

Disclosure: Disclosure(s): AbbVie: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Consultant (Ongoing); Galapagos: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Regeneron: Consultant (Ongoing); Roche: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB: Consultant (Ongoing)